Search results
‘A slap in the face’: Advocates trying to end HIV say threats to drug’s access are dangerous
Fort Worth Star-Telegram McClatchy via AOL· 1 year agoEvery night, Clint Hassell tosses a blue, square-shaped pill into his mouth, washing it down with a...
South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs
Associated Press via Yahoo News· 6 months agoSouth Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines...
Gilead Sciences: The Bull Case Is More Powerful Than You Think
GuruFocus.com via Yahoo Finance· 5 months agoGilead Sciences Inc. (NASDAQ:GILD) is an American pharmaceutical company specializing in developing...
HIV at center of latest culture war after Tennessee rejects federal funds
Washington Post via Yahoo News· 1 year agoTennessee has rejected millions of dollars from the federal government for HIV/AIDS prevention - a...
Delaware to see $1.8 million cut in HIV prevention, intervention services across the state
Delaware Online | The News Journal via Yahoo News· 6 months agoTyler Berl thought about the challenge in today’s fight against HIV. With the 35th World AIDS Day...
China approves Genuine Biotech's HIV drug for COVID patients
Reuters via Yahoo News· 2 years agoBEIJING (Reuters) -China on Monday gave conditional approval to domestic firm Genuine Biotech's...
Gilead Sciences Stock: Bear vs. Bull
Motley Fool· 1 year agoYou may know of Gilead Sciences (NASDAQ: GILD) because of its blockbuster coronavirus treatment Veklury. In fact, the S&P 500 has outperformed Gilead...
2 Cheap Dividend Stocks Yielding More Than 4%
Motley Fool· 2 years agoWhether you want to collect passive income or record market-beating returns, investing in dividend-paying companies can help you achieve both goals. And...
FDA drafts new ‘gender-inclusive’ guidance on blood donation eligibility, HIV risk reduction
The Hill via Yahoo News· 1 year agoThe Food and Drug Administration (FDA) has issued draft guidance to change its policies on donating...
FTSE 100: GSK raises guidance after strong demand for shingles vaccine
Yahoo Finance UK· 2 years agoSales of the Shingrix vaccine by GSK have more than doubled to £731m. Photo: Reuters/Loriene Perera...
